TY - JOUR
T1 - Hepatitis C virus alters the morphology and function of peroxisomes
AU - Martin de Fourchambault, Esther
AU - Callens, Nathalie
AU - Saliou, Jean Michel
AU - Fourcot, Marie
AU - Delos, Oceane
AU - Barois, Nicolas
AU - Thorel, Quentin
AU - Ramirez, Santseharay
AU - Bukh, Jens
AU - Cocquerel, Laurence
AU - Bertrand-Michel, Justine
AU - Marot, Guillemette
AU - Sebti, Yasmine
AU - Dubuisson, Jean
AU - Rouillé, Yves
N1 - Publisher Copyright:
Copyright © 2023 Martin de Fourchambault, Callens, Saliou, Fourcot, Delos, Barois, Thorel, Ramirez, Bukh, Cocquerel, Bertrand-Michel, Marot, Sebti, Dubuisson and Rouillé.
PY - 2023
Y1 - 2023
N2 - Despite the introduction of effective treatments for hepatitis C in clinics, issues remain regarding the liver disease induced by chronic hepatitis C virus (HCV) infection. HCV is known to disturb the metabolism of infected cells, especially lipid metabolism and redox balance, but the mechanisms leading to HCV-induced pathogenesis are still poorly understood. In an APEX2-based proximity biotinylation screen, we identified ACBD5, a peroxisome membrane protein, as located in the vicinity of HCV replication complexes. Confocal microscopy confirmed the relocation of peroxisomes near HCV replication complexes and indicated that their morphology and number are altered in approximately 30% of infected Huh-7 cells. Peroxisomes are small versatile organelles involved among other functions in lipid metabolism and ROS regulation. To determine their importance in the HCV life cycle, we generated Huh-7 cells devoid of peroxisomes by inactivating the PEX5 and PEX3 genes using CRISPR/Cas9 and found that the absence of peroxisomes had no impact on replication kinetics or infectious titers of HCV strains JFH1 and DBN3a. The impact of HCV on peroxisomal functions was assessed using sub-genomic replicons. An increase of ROS was measured in peroxisomes of replicon-containing cells, correlated with a significant decrease of catalase activity with the DBN3a strain. In contrast, HCV replication had little to no impact on cytoplasmic and mitochondrial ROS, suggesting that the redox balance of peroxisomes is specifically impaired in cells replicating HCV. Our study provides evidence that peroxisome function and morphology are altered in HCV-infected cells.
AB - Despite the introduction of effective treatments for hepatitis C in clinics, issues remain regarding the liver disease induced by chronic hepatitis C virus (HCV) infection. HCV is known to disturb the metabolism of infected cells, especially lipid metabolism and redox balance, but the mechanisms leading to HCV-induced pathogenesis are still poorly understood. In an APEX2-based proximity biotinylation screen, we identified ACBD5, a peroxisome membrane protein, as located in the vicinity of HCV replication complexes. Confocal microscopy confirmed the relocation of peroxisomes near HCV replication complexes and indicated that their morphology and number are altered in approximately 30% of infected Huh-7 cells. Peroxisomes are small versatile organelles involved among other functions in lipid metabolism and ROS regulation. To determine their importance in the HCV life cycle, we generated Huh-7 cells devoid of peroxisomes by inactivating the PEX5 and PEX3 genes using CRISPR/Cas9 and found that the absence of peroxisomes had no impact on replication kinetics or infectious titers of HCV strains JFH1 and DBN3a. The impact of HCV on peroxisomal functions was assessed using sub-genomic replicons. An increase of ROS was measured in peroxisomes of replicon-containing cells, correlated with a significant decrease of catalase activity with the DBN3a strain. In contrast, HCV replication had little to no impact on cytoplasmic and mitochondrial ROS, suggesting that the redox balance of peroxisomes is specifically impaired in cells replicating HCV. Our study provides evidence that peroxisome function and morphology are altered in HCV-infected cells.
KW - APEX2
KW - CRISPR-Cas9
KW - HCV genotype
KW - hepatitis C virus
KW - peroxisome
KW - proximity biotinylation
KW - ROS
U2 - 10.3389/fmicb.2023.1254728
DO - 10.3389/fmicb.2023.1254728
M3 - Journal article
C2 - 37808318
AN - SCOPUS:85173982518
SN - 1664-302X
VL - 14
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
M1 - 1254728
ER -